# Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial

> **NCT04099901** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 88 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Anakinra
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04099901
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-04
- **Primary completion:** 2023-03-14
- **Final completion:** 2024-02-26
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2024-11-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04099901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04099901, "Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04099901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*